300 related articles for article (PubMed ID: 26416462)
21. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Gratwohl A; Pfirrmann M; Zander A; Kröger N; Beelen D; Novotny J; Nerl C; Scheid C; Spiekermann K; Mayer J; Sayer HG; Falge C; Bunjes D; Döhner H; Ganser A; Schmidt-Wolf I; Schwerdtfeger R; Baurmann H; Kuse R; Schmitz N; Wehmeier A; Fischer JT; Ho AD; Wilhelm M; Goebeler ME; Lindemann HW; Bormann M; Hertenstein B; Schlimok G; Baerlocher GM; Aul C; Pfreundschuh M; Fabian M; Staib P; Edinger M; Schatz M; Fauser A; Arnold R; Kindler T; Wulf G; Rosselet A; Hellmann A; Schäfer E; Prümmer O; Schenk M; Hasford J; Heimpel H; Hossfeld DK; Kolb HJ; Büsche G; Haferlach C; Schnittger S; Müller MC; Reiter A; Berger U; Saußele S; Hochhaus A; Hehlmann R; ;
Leukemia; 2016 Mar; 30(3):562-9. PubMed ID: 26464170
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.
Castagnetti F; Gugliotta G; Breccia M; Stagno F; Iurlo A; Albano F; Abruzzese E; Martino B; Levato L; Intermesoli T; Pregno P; Rossi G; Gherlinzoni F; Leoni P; Cavazzini F; Venturi C; Soverini S; Testoni N; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G; Baccarani M;
Leukemia; 2015 Sep; 29(9):1823-31. PubMed ID: 26088952
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic analysis of chronic myeloid leukemia with Cox model and the Sokal, Hasford score].
Gan DY; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):662-6. PubMed ID: 16928295
[TBL] [Abstract][Full Text] [Related]
25. Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.
Bonifazi F; De Vivo A; Rosti G; Tiribelli M; Russo D; Trabacchi E; Fiacchini M; Montefusco E; Baccarani M
Br J Haematol; 2000 Nov; 111(2):587-95. PubMed ID: 11122107
[TBL] [Abstract][Full Text] [Related]
26. Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
Lauseker M; Hasford J; Saussele S; Kremers S; Kraemer D; Lindemann W; Hehlmann R; Pfirrmann M;
Cancer; 2017 Jul; 123(13):2467-2471. PubMed ID: 28192602
[TBL] [Abstract][Full Text] [Related]
27. Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients.
Geelen IGP; Sandin F; Thielen N; Janssen JJWM; Hoogendoorn M; Visser O; Cornelissen JJ; Hoglund M; Westerweel PE
Leukemia; 2018 Oct; 32(10):2299-2303. PubMed ID: 29743721
[No Abstract] [Full Text] [Related]
28. Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
Yhim HY; Lee NR; Song EK; Yim CY; Jeon SY; Lee B; Kim JA; Kim HS; Cho EH; Kwak JY
Acta Haematol; 2016; 135(3):133-9. PubMed ID: 26535871
[TBL] [Abstract][Full Text] [Related]
29. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.
Thota NK; Gundeti S; Linga VG; Coca P; Tara RP;
Indian J Cancer; 2014; 51(1):5-9. PubMed ID: 24947087
[TBL] [Abstract][Full Text] [Related]
30. Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.
Millot F; Guilhot J; Suttorp M; Güneş AM; Sedlacek P; De Bont E; Li CK; Kalwak K; Lausen B; Culic S; Dworzak M; Kaiserova E; De Moerloose B; Roula F; Biondi A; Baruchel A
Haematologica; 2017 Oct; 102(10):1704-1708. PubMed ID: 28838993
[TBL] [Abstract][Full Text] [Related]
31. Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.
Hasford J; Pfirrmann M; Hehlmann R; Baccarani M; Guilhot F; Mahon FX; Kluin-Nelemans HC; Ohnishi K; Thaler J; Steegmann JL;
Semin Hematol; 2003 Jan; 40(1):4-12. PubMed ID: 12563607
[TBL] [Abstract][Full Text] [Related]
32. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).
Hanfstein B; Müller MC; Hehlmann R; Erben P; Lauseker M; Fabarius A; Schnittger S; Haferlach C; Göhring G; Proetel U; Kolb HJ; Krause SW; Hofmann WK; Schubert J; Einsele H; Dengler J; Hänel M; Falge C; Kanz L; Neubauer A; Kneba M; Stegelmann F; Pfreundschuh M; Waller CF; Branford S; Hughes TP; Spiekermann K; Baerlocher GM; Pfirrmann M; Hasford J; Saußele S; Hochhaus A; ;
Leukemia; 2012 Sep; 26(9):2096-102. PubMed ID: 22446502
[TBL] [Abstract][Full Text] [Related]
33. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H
Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833
[TBL] [Abstract][Full Text] [Related]
34. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Pfirrmann M; Clark RE; Prejzner W; Lauseker M; Baccarani M; Saussele S; Guilhot F; Heibl S; Hehlmann R; Faber E; Turkina A; Ossenkoppele G; Höglund M; Zaritskey A; Griskevicius L; Olsson-Strömberg U; Everaus H; Koskenvesa P; Labar B; Sacha T; Zackova D; Cervantes F; Colita A; Zupan I; Bogdanovic A; Castagnetti F; Guilhot J; Hasford J; Hochhaus A; Hoffmann VS
Leukemia; 2020 Aug; 34(8):2138-2149. PubMed ID: 32601376
[TBL] [Abstract][Full Text] [Related]
35. EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.
Tiribelli M; Bonifacio M; Calistri E; Binotto G; Maino E; Marin L; Guardalben E; Branca A; Gherlinzoni F; Semenzato G; Sancetta R; Pizzolo G; Fanin R
Leuk Res; 2013 Nov; 37(11):1457-60. PubMed ID: 23993428
[TBL] [Abstract][Full Text] [Related]
36. Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study.
Breccia M; Pregno P; Castagnetti F; Bonifacio M; Tiribelli M; Gozzini A; Scortechini AR; Luciano L; Martino B; Stagno F; Caocci G; La Barba G; Pizzuti M; Ciccone G; Saglio G; Specchia G
Leukemia; 2021 Jun; 35(6):1814-1816. PubMed ID: 34002030
[No Abstract] [Full Text] [Related]
37. Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute - Mexico, from 2000 to 2016.
Ylescas-Soria J; de la Torre-Lujan AH; Herrera LA; Miranda D; Grimaldo F; Rivas S; Cervera E; Meneses-García A; Leon-Sarmiento FE; Prada D
Cancer Med; 2019 Jun; 8(6):2942-2949. PubMed ID: 31050162
[TBL] [Abstract][Full Text] [Related]
38. Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors.
Sasaki K; Kantarjian HM; Jain P; Jabbour EJ; Ravandi F; Konopleva M; Borthakur G; Takahashi K; Pemmaraju N; Daver N; Pierce SA; O'Brien SM; Cortes JE
Cancer; 2016 Jan; 122(2):238-48. PubMed ID: 26479889
[TBL] [Abstract][Full Text] [Related]
39. EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib.
Tao Z; Liu B; Zhao Y; Wang Y; Zhang R; Han M; Zhang L; Li C; Ru K; Mi Y; Wang J
Leuk Res; 2014 Sep; 38(9):1030-5. PubMed ID: 24996976
[TBL] [Abstract][Full Text] [Related]
40. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.
Hoffmann VS; Baccarani M; Hasford J; Castagnetti F; Di Raimondo F; Casado LF; Turkina A; Zackova D; Ossenkoppele G; Zaritskey A; Höglund M; Simonsson B; Indrak K; Sninska Z; Sacha T; Clark R; Bogdanovic A; Hellmann A; Griskevicius L; Schubert-Fritschle G; Sertic D; Guilhot J; Lejniece S; Zupan I; Burgstaller S; Koskenvesa P; Everaus H; Costeas P; Lindoerfer D; Rosti G; Saussele S; Hochhaus A; Hehlmann R
Leukemia; 2017 Mar; 31(3):593-601. PubMed ID: 27568522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]